Study of Low-Dose Radiotherapy (LDRT) Concurrent Cisplatin/Carboplatin Plus Etoposide With Atezolizumab for Patients With Extensive-Stage Small Cell Lung Cancer

NCT04622228 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

56

Enrollment

INDUSTRY

Sponsor class

Conditions

Carcinoma, Small Cell Lung

Interventions

DRUG: Atezolizumab
DRUG: Cisplatin
DRUG: Carboplatin
DRUG: Etoposide
RADIATION: Thoracic radiation therapy (TRT)

Sponsor

Hoffmann-La Roche